Trial Profile
SCOLTA: SURVEILLANCE COHORT LONG-TERM TOXICITY ANTIRETROVIRALS.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Acronyms SCOLTA
- Sponsors Boehringer Ingelheim
- 14 Dec 2008 New trial record.